Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum

Cluster analyses in NOVELTY patients with asthma and/or COPD yielded identifiable clusters, with several discriminatory features that differed from conventional diagnostic characteristics. The overlap between clusters suggests that they do not reflect discrete underlying mechanisms, and points to the need for identification of molecular endotypes and potential treatment targets across asthma and/or COPD.
Puedes leer el artículo completo aquí: https://www.sciencedirect.com/science/article/pii/S2213219823005494
Noticias relacionadas

NOVEDADES GOLD 2024 – 21 Noviembre 2023. 17-19h
NOVEDADES GOLD 2024, Reunión mixta el próximo 21 Noviembre 2023, de 17 a 19h. Regístrate cuanto antes (gratuito) en la modalidad Online o Presencial.

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
The results of this post hoc analysis support the hypothesis that benralizumab reduces the risk for recurrent COPD exacerbations within the vulnerable 30-to-90–day period in the previously identified responder population.

Alvar Agustí presentations on COPD GOLD 2023 webinar
Mediante esta noticia ponemos a vuestra disposición los documentos de las presentaciones de Alvar Agustí durante la sesión del Webinar «JOINT WEBINAR ON COPD 2023 GUIDELINES»
Más artículos
Astma
- Alvar Agusti, Peter G. Gibson, Vanessa M. McDonald. Treatable Traits in Airway Disease: From Theory to Practice
- Teresa M Kole et Al. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
- Alvar Agustí, Eleni Rapsomaniki, Richard Beasley, Rod Hughes, Hana Müllerová, Alberto Papi,Ian D. Pavord, Maarten van den Berge, Rosa Faner – Treatable traits in the NOVELTY study1. 2022
- H. Abozid et al. Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria, 2021
- Agusti, A., et al., Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications. Allergy, 2022. 77(4): p. 1105-1113
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en PDF de publicación original.